Literature DB >> 19575749

Effect of the alcoholic extract of Ashwagandha leaves and its components on proliferation, migration, and differentiation of glioblastoma cells: combinational approach for enhanced differentiation.

Navjot Shah1, Hardeep Kataria, Sunil C Kaul, Tetsuro Ishii, Gurcharan Kaur, Renu Wadhwa.   

Abstract

Ashwagandha (Withania somnifera) is widely used in the Indian traditional system of medicine, Ayurveda. Although it is claimed to have a large variety of health-promoting effects, including therapeutic effects on stress and disease, the mechanisms of action have not yet been determined. In the present study, we aimed to investigate the growth inhibition and differentiation potential of the alcoholic extract of Ashwagandha leaves (i-Extract), its different constituents (Withaferin A, Withanone, Withanolide A) and their combinations on glioma (C6 and YKG1) cell lines. Withaferin A, Withanone, Withanolide A and i-Extract markedly inhibited the proliferation of glioma cells in a dose-dependent manner and changed their morphology toward the astrocytic type. Molecular analysis revealed that the i-Extract and some of its components caused enhanced expression of glial fibrillary acidic protein, change in the immunostaining pattern of mortalin from perinuclear to pancytoplasmic, delay in cell migration, and increased expression of neuronal cell adhesion molecules. The data suggest that the i-Extract and its components have the potential to induce senescence-like growth arrest and differentiation in glioma cells. These assays led us to formulate a unique combination formula of i-Extract components that caused enhanced differentiation of glial cells.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19575749     DOI: 10.1111/j.1349-7006.2009.01236.x

Source DB:  PubMed          Journal:  Cancer Sci        ISSN: 1347-9032            Impact factor:   6.716


  29 in total

1.  Assessment of Cholinergic Properties of Ashwagandha Leaf-Extract in the Amnesic Mouse Brain.

Authors:  Akash Gautam; Renu Wadhwa; Mahendra K Thakur
Journal:  Ann Neurosci       Date:  2016-07-07

2.  Oxidative cytotoxic agent withaferin A resensitizes temozolomide-resistant glioblastomas via MGMT depletion and induces apoptosis through Akt/mTOR pathway inhibitory modulation.

Authors:  Patrick T Grogan; Jann N Sarkaria; Barbara N Timmermann; Mark S Cohen
Journal:  Invest New Drugs       Date:  2014-04-10       Impact factor: 3.850

Review 3.  Withaferin A and its potential role in glioblastoma (GBM).

Authors:  Jasdeep Dhami; Edwin Chang; Sanjiv S Gambhir
Journal:  J Neurooncol       Date:  2016-11-11       Impact factor: 4.130

4.  Withania somnifera Suppresses Tumor Growth of Intracranial Allograft of Glioma Cells.

Authors:  Hardeep Kataria; Sushil Kumar; Harshita Chaudhary; Gurcharan Kaur
Journal:  Mol Neurobiol       Date:  2015-07-26       Impact factor: 5.590

Review 5.  Molecular targets and mechanisms of cancer prevention and treatment by withaferin a, a naturally occurring steroidal lactone.

Authors:  Avani R Vyas; Shivendra V Singh
Journal:  AAPS J       Date:  2013-09-18       Impact factor: 4.009

6.  Selective killing of cancer cells by Ashwagandha leaf extract and its component Withanone involves ROS signaling.

Authors:  Nashi Widodo; Didik Priyandoko; Navjot Shah; Renu Wadhwa; Sunil C Kaul
Journal:  PLoS One       Date:  2010-10-21       Impact factor: 3.240

7.  Cytotoxicity of withaferin A in glioblastomas involves induction of an oxidative stress-mediated heat shock response while altering Akt/mTOR and MAPK signaling pathways.

Authors:  Patrick T Grogan; Kristina D Sleder; Abbas K Samadi; Huaping Zhang; Barbara N Timmermann; Mark S Cohen
Journal:  Invest New Drugs       Date:  2012-11-06       Impact factor: 3.850

Review 8.  Treatment of adult and pediatric high-grade gliomas with Withaferin A: antitumor mechanisms and future perspectives.

Authors:  Megan M Marlow; Sumedh S Shah; Eduardo A Véliz; Michael E Ivan; Regina M Graham
Journal:  J Nat Med       Date:  2016-07-02       Impact factor: 2.343

9.  Anti-Stress and Glial Differentiation Effects of a Novel Combination of Cucurbitacin B and Withanone (CucWi-N): Experimental Evidence.

Authors:  Sukant Garg; Sunil C Kaul; Renu Wadhwa
Journal:  Ann Neurosci       Date:  2018-07-05

10.  Withania somnifera water extract as a potential candidate for differentiation based therapy of human neuroblastomas.

Authors:  Hardeep Kataria; Renu Wadhwa; Sunil C Kaul; Gurcharan Kaur
Journal:  PLoS One       Date:  2013-01-31       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.